Cite
Jones SB, Pfeifer LA, Bleisch TJ, et al. Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design. ACS Med Chem Lett. 2016;7(9):857-61doi: 10.1021/acsmedchemlett.6b00207.
Jones, S. B., Pfeifer, L. A., Bleisch, T. J., Beauchamp, T. J., Durbin, J. D., Klimkowski, V. J., Hughes, N. E., Rito, C. J., Dao, Y., Gruber, J. M., Bui, H., Chambers, M. G., Chandrasekhar, S., Lin, C., McCann, D. J., Mudra, D. R., Oskins, J. L., Swearingen, C. A., Thirunavukkarasu, K., & Norman, B. H. (2016). Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design. ACS medicinal chemistry letters, 7(9), 857-61. https://doi.org/10.1021/acsmedchemlett.6b00207
Jones, Spencer B, et al. "Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design." ACS medicinal chemistry letters vol. 7,9 (2016): 857-61. doi: https://doi.org/10.1021/acsmedchemlett.6b00207
Jones SB, Pfeifer LA, Bleisch TJ, Beauchamp TJ, Durbin JD, Klimkowski VJ, Hughes NE, Rito CJ, Dao Y, Gruber JM, Bui H, Chambers MG, Chandrasekhar S, Lin C, McCann DJ, Mudra DR, Oskins JL, Swearingen CA, Thirunavukkarasu K, Norman BH. Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design. ACS Med Chem Lett. 2016 Aug 02;7(9):857-61. doi: 10.1021/acsmedchemlett.6b00207. eCollection 2016 Sep 08. PMID: 27660691; PMCID: PMC5018868.
Copy
Download .nbib